ES2194008T3 - Proteina p100 del virus del herpes humano tipo 6, las correspondientes secuencias de adn, su preparacion y uso. - Google Patents

Proteina p100 del virus del herpes humano tipo 6, las correspondientes secuencias de adn, su preparacion y uso.

Info

Publication number
ES2194008T3
ES2194008T3 ES92110047T ES92110047T ES2194008T3 ES 2194008 T3 ES2194008 T3 ES 2194008T3 ES 92110047 T ES92110047 T ES 92110047T ES 92110047 T ES92110047 T ES 92110047T ES 2194008 T3 ES2194008 T3 ES 2194008T3
Authority
ES
Spain
Prior art keywords
dna sequences
corresponding dna
protein
preparation
virus type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92110047T
Other languages
English (en)
Inventor
Frank Neipel
Bernhard Fleckenstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Application granted granted Critical
Publication of ES2194008T3 publication Critical patent/ES2194008T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16511—Roseolovirus, e.g. human herpesvirus 6, 7
    • C12N2710/16522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/94—Saccharomyces
    • Y10S435/942—Saccharomyces cerevisiae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A LA PROTEINA P100 TIPO 6 DEL VIRUS DEL HERPES HUMANO Y A PARTES DE LA MISMA QUE TIENEN SUS PROPIEDADES INMUNOLOGICAS ESPECIFICAS. SE REFIERE ADEMAS A ANTICUERPOS DIRIGIDOS A LAS MISMAS Y A LAS SECUENCIAS DE ADN CORRESPONDIENTES. SE PUEDEN UTILIZAR EN COMPOSICIONES FARMACEUTICAS Y DE DIAGNOSTICO, Y DE MANERA OPCIONAL JUNTO CON OTRAS PROTEINAS HHV-6 O LAS SECUENCIAS DE ADN CORRESPONDIENTES.
ES92110047T 1991-07-08 1992-06-15 Proteina p100 del virus del herpes humano tipo 6, las correspondientes secuencias de adn, su preparacion y uso. Expired - Lifetime ES2194008T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91111338 1991-07-08

Publications (1)

Publication Number Publication Date
ES2194008T3 true ES2194008T3 (es) 2003-11-16

Family

ID=8206915

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92110047T Expired - Lifetime ES2194008T3 (es) 1991-07-08 1992-06-15 Proteina p100 del virus del herpes humano tipo 6, las correspondientes secuencias de adn, su preparacion y uso.

Country Status (10)

Country Link
US (3) US5814475A (es)
EP (1) EP0524421B1 (es)
JP (1) JP3425164B2 (es)
AT (1) ATE235553T1 (es)
AU (1) AU666482B2 (es)
CA (1) CA2073282C (es)
DE (1) DE69232975T2 (es)
DK (1) DK0524421T3 (es)
ES (1) ES2194008T3 (es)
PT (1) PT524421E (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003605A2 (en) * 1992-07-31 1994-02-17 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for detecting human herpesvirus 6 strain z29
ATE240398T1 (de) 1997-07-11 2003-05-15 Fleckenstein Bernard Prof Dr Von kaposi-sarkom assoziiertem herpes-virus (kshv,hhv-8) kodiertes polypeptid und dessen verwendung in diagnostik und therapie
SE528319C2 (sv) * 2004-09-17 2006-10-17 Forskarpatent I Syd Ab Användning av humant herpesvirus 6 eller derivat av dessa för tillverkning av en farmaceutisk komposition för förebyggandet av atopi eller atopisk sjukdom, inklusive astma, hos barn
US20090181889A1 (en) * 2006-03-08 2009-07-16 University Of Rochester Compositions and methods for detection and treatment of human herpesvirus (hhv)-6

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4013536A1 (de) * 1989-05-04 1990-11-08 Univ Kansas Monoclonaler antikoerper fuer mit hhv-6 infizierte zellen und deren proteinmaterial sowie seine anwendungen
FR2651007B1 (fr) * 1989-08-18 1992-09-04 Pasteur Institut Fragments d'acides nucleiques et reactifs de diagnostic derives du genome de hhv6/sie et procede de diagnostic des infections a hhv6
DE4013526C2 (de) * 1990-04-27 1994-04-28 Rutenbeck Wilhelm Gmbh & Co Schaltungsanordnung zum Übertragen von Daten zwischen mehreren Geräten über eine Busleitung

Also Published As

Publication number Publication date
JP3425164B2 (ja) 2003-07-07
JPH06113858A (ja) 1994-04-26
AU666482B2 (en) 1996-02-15
CA2073282C (en) 2005-12-06
US5827519A (en) 1998-10-27
US5814475A (en) 1998-09-29
US6174685B1 (en) 2001-01-16
EP0524421A1 (en) 1993-01-27
ATE235553T1 (de) 2003-04-15
EP0524421B1 (en) 2003-03-26
DK0524421T3 (da) 2003-07-21
DE69232975T2 (de) 2004-03-04
PT524421E (pt) 2003-08-29
AU1945592A (en) 1993-01-14
CA2073282A1 (en) 1993-01-09
DE69232975D1 (de) 2003-04-30

Similar Documents

Publication Publication Date Title
ATE118352T1 (de) Erreger der mysteriösen schweinekrankheit,impfstoff-zusammensetzungen und diagnose kits.
CA2113712A1 (en) Papilloma virus vaccine
DE68929546D1 (de) Menschlicher Fc-gamma-Rezeptor III
GB2255093A (en) Hiv-1 core protein fragments
DE3750342T2 (de) Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen.
ATE317852T1 (de) Pollen allergene
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
DE68925275T2 (de) Endotoxin-bindeprotein und dessen verwendung
DE60125537D1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
DE69530380D1 (de) Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik
ES2194008T3 (es) Proteina p100 del virus del herpes humano tipo 6, las correspondientes secuencias de adn, su preparacion y uso.
ATE191568T1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
CA2132742A1 (en) Synthetic Peptides and Vaccines Against Parvovirus
DK0412766T3 (da) Peptidfragmenter af HIV
DE69011122T2 (de) Rubella-e1 und c peptide.
ATE189262T1 (de) Interferon-alpha/beta bindendes protein, seine herstellung und seine enthaltende pharmazeutische zusammensetzungen
DE60029327D1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
ES2142317T3 (es) Polipeptidos de proteinas s y uso de los mismos.
ES2095258T3 (es) Nuevo virus de la enfermedad de la bolsa infecciosa.
CA2141670A1 (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
ATE79638T1 (de) Polypeptide, deren kodierende peptide und methode zur herstellung dieser peptide und dnas.
SE9604439D0 (sv) New receptor
BR1100801A (pt) Proteìna, peptìdeo, proteìna ou peptìdeo, sequência de dna, processo para a preparação de uma proteìna ou peptìdeo, anticorpo, composição farmacêutica, e, uso de uma proteìna ou peptìdeo
ZA982996B (en) Synthetic peptides which can be used in biological tests for the detection of infections due to group O HIV-1 viruses.
BR8902460A (pt) Processo para preparacao de hidrolisado de proteina de baixa imunogenicidade e antigenicidade,para uso enteral